-
3
-
-
58149135005
-
-
J.T. Taylor, X.B. Zeng, J.E. Pottle, K. Lee, A.R. Wang, S.G. Yi, J.A. Scruggs, S.S. Sikka, and M. Li World J. Gastroenterol. 28 2008 4984
-
(2008)
World J. Gastroenterol.
, vol.28
, pp. 4984
-
-
Taylor, J.T.1
Zeng, X.B.2
Pottle, J.E.3
Lee, K.4
Wang, A.R.5
Yi, S.G.6
Scruggs, J.A.7
Sikka, S.S.8
Li, M.9
-
4
-
-
2942536387
-
-
W.F. McCalmont, T.N. Heady, J.R. Patterson, M.A. Lindenmuth, D.M. Haverstick, L.S. Gray, and T.L. Macdonald Bioorg. Med. Chem. Lett. 14 2004 3691
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 3691
-
-
McCalmont, W.F.1
Heady, T.N.2
Patterson, J.R.3
Lindenmuth, M.A.4
Haverstick, D.M.5
Gray, L.S.6
MacDonald, T.L.7
-
5
-
-
47249156681
-
-
J.H. Heo, H.N. Seo, Y.J. Choe, S. Kim, C.R. Oh, Y.D. Kim, H. Rhim, D.J. Choo, J. Kim, and J.Y. Lee Bioorg. Med. Chem. Lett. 18 2008 3899
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 3899
-
-
Heo, J.H.1
Seo, H.N.2
Choe, Y.J.3
Kim, S.4
Oh, C.R.5
Kim, Y.D.6
Rhim, H.7
Choo, D.J.8
Kim, J.9
Lee, J.Y.10
-
6
-
-
33747334641
-
-
J.Y. Lee, S.J. Park, S.J. Park, M.J. Lee, H. Rhim, S.H. Seo, and K.S. Kim Bioorg. Med. Chem. Lett. 16 2006 5014
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 5014
-
-
Lee, J.Y.1
Park, S.J.2
Park, S.J.3
Lee, M.J.4
Rhim, H.5
Seo, S.H.6
Kim, K.S.7
-
7
-
-
45849103510
-
-
J.T. Taylor, L. Huang, J.E. Pottle, K. Liu, Y. Yang, X. Zeng, B.M. Keyser, K.C. Agrawal, J.B. Hansen, and M. Li Cancer Lett. 267 2008 116
-
(2008)
Cancer Lett.
, vol.267
, pp. 116
-
-
Taylor, J.T.1
Huang, L.2
Pottle, J.E.3
Liu, K.4
Yang, Y.5
Zeng, X.6
Keyser, B.M.7
Agrawal, K.C.8
Hansen, J.B.9
Li, M.10
-
8
-
-
0037192821
-
-
P. Mariot, K. Vanoverberghe, N. Lalevee, M.F. Rossier, and N. Prevarskaya J. Biol. Chem. 277 2002 10824
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 10824
-
-
Mariot, P.1
Vanoverberghe, K.2
Lalevee, N.3
Rossier, M.F.4
Prevarskaya, N.5
-
9
-
-
0036073980
-
-
G.E. Bertolesi, C. Shi, L. Elbaum, C. Jollimore, G. Rozenberg, S. Barnes, and M.E. Kelly Mol. Pharmacol. 62 2002 210
-
(2002)
Mol. Pharmacol.
, vol.62
, pp. 210
-
-
Bertolesi, G.E.1
Shi, C.2
Elbaum, L.3
Jollimore, C.4
Rozenberg, G.5
Barnes, S.6
Kelly, M.E.7
-
10
-
-
37849017902
-
-
F. Lu, H. Chen, C. Zhou, S. Liu, M. Guo, P. Chen, H. Zhuang, D. Xie, and S. Wu Cell Calcium 43 2008 49
-
(2008)
Cell Calcium
, vol.43
, pp. 49
-
-
Lu, F.1
Chen, H.2
Zhou, C.3
Liu, S.4
Guo, M.5
Chen, P.6
Zhuang, H.7
Xie, D.8
Wu, S.9
-
11
-
-
10944232060
-
-
A. Panner, L.L. Cribbs, G.M. Zainelli, T.C. Origitano, S. Singh, and R.D. Wurster Cell Calcium 37 2005 105
-
(2005)
Cell Calcium
, vol.37
, pp. 105
-
-
Panner, A.1
Cribbs, L.L.2
Zainelli, G.M.3
Origitano, T.C.4
Singh, S.5
Wurster, R.D.6
-
12
-
-
24644491717
-
-
M. Li, J.B. Hansen, L. Huang, B.M. Keyser, and J.T. Taylor Cardiovasc. Drug Rev. 23 2005 173
-
(2005)
Cardiovasc. Drug Rev.
, vol.23
, pp. 173
-
-
Li, M.1
Hansen, J.B.2
Huang, L.3
Keyser, B.M.4
Taylor, J.T.5
-
14
-
-
10644273394
-
-
H. Rhim, Y.S. Lee, S.J. Park, B.Y. Chung, and J.Y. Lee Bioorg. Med. Chem. Lett. 15 2005 283
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 283
-
-
Rhim, H.1
Lee, Y.S.2
Park, S.J.3
Chung, B.Y.4
Lee, J.Y.5
-
15
-
-
84855323238
-
-
Appendix 3, Appendix 3B. Trypan blue exclusion test: A549 cells, cultured in the presence of KYS05047 at various concentrations (0, 4, 6, 8, 10, and 12 μM) for different times (0, 6, 12, 24, 36, and 48 h), were collected by centrifugation and resuspended with 0.4% trypan blue solution. And then incubate 3 min at room temperature and viable cells (unstained cells) were counted using hemocytometer
-
W. Strober Curr. Protoc. Immunol. 1 2001 2 Appendix 3, Appendix 3B. Trypan blue exclusion test: A549 cells, cultured in the presence of KYS05047 at various concentrations (0, 4, 6, 8, 10, and 12 μM) for different times (0, 6, 12, 24, 36, and 48 h), were collected by centrifugation and resuspended with 0.4% trypan blue solution. And then incubate 3 min at room temperature and viable cells (unstained cells) were counted using hemocytometer
-
(2001)
Curr. Protoc. Immunol.
, vol.1
, pp. 2
-
-
Strober, W.1
-
16
-
-
84870441818
-
-
Cell cycle analysis: cells were treated with various concentrations of KYS05047, and then washed with 1 ml phosphate-buffered saline (PBS), fixed in 70% ice-cold ethanol and kept in a freezer overnight. The fixed cells were centrifuged, washed twice with PBS and re-suspended in PBS containing 50 mg/ml PI and 100 μg/ml DNase-free RNase A. The cell suspension, which was hidden from light, was incubated for 30 min and analyzed using the fluorescence- activated cell sorting cater-plus FACS (Becton Dickinson Co, Heidelberg, Germany)
-
K.W. Lee, H.J. Kim, Y.S. Lee, H.J. Park, J.W. Choi, J. Ha, and K.T. Lee Carcinogenesis 2007 1928 28 Cell cycle analysis: cells were treated with various concentrations of KYS05047, and then washed with 1 ml phosphate-buffered saline (PBS), fixed in 70% ice-cold ethanol and kept in a freezer overnight. The fixed cells were centrifuged, washed twice with PBS and re-suspended in PBS containing 50 mg/ml PI and 100 μg/ml DNase-free RNase A. The cell suspension, which was hidden from light, was incubated for 30 min and analyzed using the fluorescence-activated cell sorting cater-plus FACS (Becton Dickinson Co, Heidelberg, Germany)
-
(1928)
Carcinogenesis
, vol.2007
, pp. 28
-
-
Lee, K.W.1
Kim, H.J.2
Lee, Y.S.3
Park, H.J.4
Choi, J.W.5
Ha, J.6
Lee, K.T.7
-
17
-
-
80055015168
-
-
E.J. Cho, H.J. An, J.S. Shin, H.E. Choi, J. Ko, Y.W. Cho, H.M. Kim, J.H. Choi, and K.T. Lee J. Cell. Biochem. 112 2011 3648 Western blotting: cells were collected by centrifugation and washed once with PBS.
-
(2011)
J. Cell. Biochem.
, vol.112
, pp. 3648
-
-
Cho, E.J.1
An, H.J.2
Shin, J.S.3
Choi, H.E.4
Ko, J.5
Cho, Y.W.6
Kim, H.M.7
Choi, J.H.8
Lee, K.T.9
-
20
-
-
0032488972
-
-
F. Casagrande, D. Bacqueville, M.J. Pillaire, F. Malecaze, S. Manenti, M. Breton-Douillon, and J.M. Darbon FEBS Lett. 422 1998 385
-
(1998)
FEBS Lett.
, vol.422
, pp. 385
-
-
Casagrande, F.1
Bacqueville, D.2
Pillaire, M.J.3
Malecaze, F.4
Manenti, S.5
Breton-Douillon, M.6
Darbon, J.M.7
-
21
-
-
33645506912
-
-
H. Yang, Y. Zhang, R. Zhao, Y.Y. Wen, K. Fournier, H.B. Wu, H.Y. Yang, J. Diaz, C. Laronga, and M.H. Lee Oncogene 25 2006 4585
-
(2006)
Oncogene
, vol.25
, pp. 4585
-
-
Yang, H.1
Zhang, Y.2
Zhao, R.3
Wen, Y.Y.4
Fournier, K.5
Wu, H.B.6
Yang, H.Y.7
Diaz, J.8
Laronga, C.9
Lee, M.H.10
-
22
-
-
0034015954
-
-
2+ concentration was measured using Flou-4 calcium assay kit (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions
-
2+ concentration was measured using Flou-4 calcium assay kit (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions
-
(2000)
Cell Calcium
, vol.27
, pp. 97
-
-
Gee, K.R.1
Brown, K.A.2
Chen, W.N.3
Bishop-Stewart, J.4
Gray, D.5
Johnson, I.6
-
23
-
-
0034007563
-
-
D.M. Zhao, H.H. Xue, K. Chida, T. Suda, Y. Oki, M. Kanai, C. Uchida, A. Ichiyama, and H. Nakamura Am J. Physiol. Lung Cell. Mol. Physiol. 278 2000 L726
-
(2000)
Am J. Physiol. Lung Cell. Mol. Physiol.
, vol.278
, pp. 726
-
-
Zhao, D.M.1
Xue, H.H.2
Chida, K.3
Suda, T.4
Oki, Y.5
Kanai, M.6
Uchida, C.7
Ichiyama, A.8
Nakamura, H.9
-
27
-
-
84855659193
-
-
A549 xenograft model: A549 cells (5 × 106 cells/mice) were injected subcutaneously into the left flank of BALB/cnu/nu mice. Mice were separated into four groups (n = 7). After 8 days when average tumor volume reached approximately 50-100 mm3, paclitaxel (20 mg/kg; twice/week; ip) and KYS05047 (2 or 10 mg/kg; 5 times/week; po) were administered for 21 days. Tumor lengths and widths were measured using a caliper and tumor volume was calculated as 1/2 × length × width2 until animal sacrifice. Control animals and the animals treated with paclitaxel or KYS05047 were euthanized after 21 days and the tumors were excised. Tumor weights of each group were measured and the representative tumors were photographed
-
H.B. Kang, H.K. Rim, J.Y. Park, H.W. Choi, D.L. Choi, J.H. Seo, K.S. Chung, G. Huh, J. Kim, D.J. Choo, K.T. Lee, and J.Y. Lee Bioorg. Med. Chem. Lett. 22 2012 1198 A549 xenograft model: A549 cells (5 × 106 cells/mice) were injected subcutaneously into the left flank of BALB/cnu/nu mice. Mice were separated into four groups (n = 7). After 8 days when average tumor volume reached approximately 50-100 mm3, paclitaxel (20 mg/kg; twice/week; ip) and KYS05047 (2 or 10 mg/kg; 5 times/week; po) were administered for 21 days. Tumor lengths and widths were measured using a caliper and tumor volume was calculated as 1/2 × length × width2 until animal sacrifice. Control animals and the animals treated with paclitaxel or KYS05047 were euthanized after 21 days and the tumors were excised. Tumor weights of each group were measured and the representative tumors were photographed
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 1198
-
-
Kang, H.B.1
Rim, H.K.2
Park, J.Y.3
Choi, H.W.4
Choi, D.L.5
Seo, J.H.6
Chung, K.S.7
Huh, G.8
Kim, J.9
Choo, D.J.10
Lee, K.T.11
Lee, J.Y.12
|